[PDF][PDF] Experience with Argon Plasma Coagulation in Treatment of Recurrent Epistaxis in Patients with Hereditary Hemorrhagic Telangiectasia

F Alžběta, L Dostálová, J Plzák - B-ENT, 2022 - b-ent.be
Objective: Hereditary hemorrhagic telangiectasia, or Rendu-Osler-Weber disease, is an
autosomal dominant genetic disorder characterized by abnormal vessel formation …

Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia

F Pagella, L Semino, C Olivieri… - American journal of …, 2006 - journals.sagepub.com
Background Recurrent epistaxis is the most common manifestation of hereditary
hemorrhagic telangiectasia (HHT). The aim of this study was to determine the role and …

Argon plasma coagulation is an effective treatment for hereditary hemorrhagic telangiectasia patients with severe nosebleeds

F Pagella, E Matti, F Chu, A Pusateri… - Acta Oto …, 2013 - Taylor & Francis
Conclusions: In contrast to the current trend according to which the treatment of hereditary
hemorrhagic telangiectasia (HHT) epistaxis depends on clinical severity, argon plasma …

Argon plasma coagulation in treatment of hereditary hemorrhagic telangiectasia of the nasal mucosa

W Bergler, K Götte, F Riedel, W Back, K Hörmann - HNO, 1998 - europepmc.org
Patients with hereditary hemorrhagic telangiectasia (M. Osler-Rendu-Weber disease) often
suffer from recurrent epistaxis that poses considerable therapeutic problems. Dermoplasty …

[HTML][HTML] Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia

ML FIORELLA, L Lillo, R Fiorella - Acta Otorhinolaryngologica …, 2012 - ncbi.nlm.nih.gov
Periodic and spontaneous nosebleed is the most common clinical manifestation of
hereditary haemorrhagic telangiectasia (HHT), present in 95% of patients suffering from this …

Hereditary hemorrhagic telangiectasia: what the otolaryngologist should know

SV Byahatti, EE Rebeiz… - American Journal of …, 1997 - journals.sagepub.com
Hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease is a systemic
autosomal dominant disorder involving blood vessels. Phenotypically, the disease presents …

[PDF][PDF] A modified technique for septodermoplasty in hereditary hemorrhagic telangiectasia

J Rimmer, VJ Lund - The Laryngoscope, 2014 - researchgate.net
INTRODUCTION Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-
Rendu syndrome, is an autosomal dominant vascular disease with an incidence of …

Coblation for epistaxis management in patients with hereditary haemorrhagic telangiectasia: a multicentre case series

H Joshi, BA Woodworth, AS Carney - The Journal of Laryngology & …, 2011 - cambridge.org
Objective: To propose radiofrequency coblation as a potential treatment modality for mild to
moderate epistaxis in patients with hereditary haemorrhagic telangiectasia. Method: Case …

Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia

W Bergler, H Sadick, F Riedel… - Annals of Otology …, 2002 - journals.sagepub.com
The aim of this study was to assess the value of topically applied estrogens in patients with
hereditary hemorrhagic telangiectasia. Twenty-six patients with this disorder were treated …

[HTML][HTML] Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience

F Pagella, A Pusateri, E Maiorano… - Acta …, 2021 - ncbi.nlm.nih.gov
Objectives Hereditary haemorrhagic telangiectasia (HHT) is a rare autosomal dominant
disease characterised by epistaxis. Surgical procedures for epistaxis vary from …